Market Tracker

12/19 6:05pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

95.46
Data as of Dec 19
 +0.46 / +0.48%
Today’s Change
60.19
Today|||52-Week Range
119.42
+47.50%
Year-to-Date

Today’s Trading

Previous close95.00
Today’s open94.80
Day’s range94.08 - 98.38
Volume563,719
Average volume (3 months)248,407
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-72.72%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book6.83

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+1.02+1.12%
XONIntrexon Corp+0.39+1.41%
KITEKite Pharma Inc+0.80+1.52%
OPHTOphthotech Corp-0.47-0.99%
Data as of 4:01pm ET, 12/19/2014

Financials

Next reporting dateMarch 9, 2015
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts